Statement Of Cash Flows [Abstract]

Cinclus Pharma Holding AB - Filing #5879290

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
162 195 SEK
201 581 SEK
Adjustments for decrease (increase) in trade and other receivables
27 512 SEK
5 642 SEK
Adjustments for increase (decrease) in other liabilities
8 860 SEK
12 701 SEK
Income taxes paid, classified as operating activities
7 437 SEK
6 784 SEK
Cash flows from (used in) financing activities [abstract]
Cash advances and loans from related parties
SEK
124 343 SEK
Payments for share issue costs
58 424 SEK
167,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.